Hajnik, Renee L.
Plante, Jessica A. http://orcid.org/0000-0002-4768-7458
Reddy Bonam, Srinivasa http://orcid.org/0000-0002-2888-2418
Rafael, Grace H.
Liang, Yuejin http://orcid.org/0000-0002-9557-1847
Hazell, Nicholas C.
Walker, Jordyn
Reyna, Rachel A. http://orcid.org/0000-0001-8421-8397
Walker, David H.
Alameh, Mohamad-Gabriel http://orcid.org/0000-0002-5672-6930
Weissman, Drew
Weaver, Scott C. http://orcid.org/0000-0001-8016-8556
Plante, Kenneth S. http://orcid.org/0000-0002-7485-3167
Hu, Haitao http://orcid.org/0000-0002-6964-2314
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R24AI120942, R41AI181134, R24AI120942, R24AI120942)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 29 March 2024
Accepted: 21 August 2024
First Online: 4 September 2024
Competing interests
: H.H. and D.W. are inventors on a patent (PCT) titled COVID-19 mRNA vaccine (WO2023056045A1). All other authors declare no competing interests where relevant.